O33 Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis

التفاصيل البيبلوغرافية
العنوان:	O33 Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis
المؤلفون:	Furie, Richard A, Tas, Sander W, Malvar, Ana, Looney, Cary M, Raghu, Harini, Anania, Veronica G, Mao, Ashley, Schindler, Thomas, Martins, Elsa, Ross Terres, Jorge A, Vital, Edward M
المصدر:	Oral Presentations ; page A31-A33
بيانات النشر:	Lupus Foundation of America
سنة النشر:	2024
نوع الوثيقة:	conference object
اللغة:	unknown
DOI:	10.1136/lupus-2024-el.42
الاتاحة:	http://dx.doi.org/10.1136/lupus-2024-el.42 https://syndication.highwire.org/content/doi/10.1136/lupus-2024-el.42
Rights:	http://creativecommons.org/licenses/by-nc/4.0/
رقم الانضمام:	edsbas.7D693989
قاعدة البيانات:	BASE

الوصف
DOI:	10.1136/lupus-2024-el.42